Dr. Bhan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
15 Parkman Street
Wang 5
Boston, MA 02114Phone+1 617-726-5925Fax+1 617-724-6832
Summary
- Dr. Irun Bhan is a gastroenterologist and transplant hepatologist in Boston, MA and is affiliated with Massachusetts General Hospital. He received his medical degree from Harvard Medical School. He serves as the Medical Director of Living Donor Liver Transplantation and the Medical Director of the Liver Tumor Program.
Education & Training
Massachusetts General HospitalFellowship, Transplant Hepatology, 2017 - 2018- Massachusetts General HospitalFellowship, Gastroenterology, 2017
New York Presbyterian Hospital (Columbia Campus)Chief Residency, Internal Medicine, 2013 - 2014- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2010 - 2013
Harvard Medical SchoolClass of 2010
Certifications & Licensure
MA State Medical License 2014 - 2025
NY State Medical License 2013 - 2015- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2013-2016
Publications & Presentations
PubMed
- 10 citationsResection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies.Surendra Pal Chaudhary, Stephanie Reyes, Matthew L Chase, Aparna Govindan, Lei Zhao
The Oncologist. 2023-04-06 - 288 citationsRecurrent Initiation: A Mechanism for Triggering p53 Pulses in Response to DNA DamageEric Batchelor, Caroline Mock, Irun Bhan, Alexander Loewer, Galit Lahav
Molecular Cell. 2008-05-09 - 55 citationsPancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target.Joseph W. Franses, Julia Philipp, Pavlos Missios, Irun Bhan, A. W. K. Liu
Nature Communications. 2020-07-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
